CS logo
small CS logo
Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative

Milano, Lombardia, Italy
Nursing home in Milan
Via Giuseppe Dezza, 48, 20144 Milano MI

About Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative


During the past decade, Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative" #1 collaborator was "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative


According to Clinical.Site data, the most researched conditions in "Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative" are "Alzheimer's Disease" (2 trials), "Alzheimer Disease" (1 trials) and "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (1 trials). Many other conditions were trialed in "Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative" in a lesser frequency.

Clinical Trials Intervention Types at Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative


Most popular intervention types in "Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "0.25% albumin placebo solution with rHuPH20" (1 trials), "Aducanumab (BIIB037)" (1 trials), "Crenezumab" (1 trials) and "Gantenerumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative


The vast majority of trials in "Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative" are 4 trials for "All" genders.

Clinical Trials Status at Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative


Currently, there are NaN active trials in "Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Casa di Cura Policlinico; Dipartimento di Scienze Neuroriabilitative, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".